Annovis Bio’s stock rockets 119% after reporting positive data in Parkinson’s disease trial 2 de julho de 2024 by in News The stock is on track for its best performance since May 21, 2021, when it gained 127%. Compartilhe isso:Clique para compartilhar no Twitter(abre em nova janela)Clique para compartilhar no Facebook(abre em nova janela) Relacionado 2 de julho de 2024